Page 374 - SAHCS HIVMed Journal Vol 20 No 1 2019
P. 374

Southern African Journal of HIV Medicine
              ISSN: (Online) 2078-6751, (Print) 1608-9693
                                                       Page 1 of 8  Original Research


                      Neurodevelopment at 11 months after starting

                         antiretroviral therapy within 3 weeks of life






               Authors:                 Background: Antiretroviral therapy (ART) started between 7 and 12 weeks of age improves
               Barbara Laughton         neurodevelopmental outcomes in HIV-infected (HIV+) infants, but the impact of even earlier
                          1
               Shalena Naidoo   2
               Els F.M.T. Dobbels   1   initiation is not yet described.
               Michael J. Boivin
                         3,4
               Anita Janse van Rensburg   1  Objectives: We assessed the early neurodevelopment of HIV+ infants who started ART within
               Richard H. Glashoff      21 days of life.
                           2,5
               Gert U. van Zyl
                        5,6
               Mariana Kruger   1       Method: Participants were enrolled from the public sector birth HIV-diagnosis programme.
               Mark F. Cotton           Inclusion criteria included the following: birth weight > 2000 g, infant commencing ART
                        1
                                        <  6  weeks and no infant cytomegalovirus disease.  Antiretroviral therapy included
               Affiliations:            Zidovudine/Lamivudine/Nevirapine  for  the  first  2  weeks,  the  latter  then  replaced  by
               1 Department of Paediatrics
               and Child Health,        Lopinavir/Ritonavir. Once body weight > 3 kg and gestational age > 44 weeks, Abacavir
               Stellenbosch University,   replaced Zidovudine. The Griffiths mental development scales (GMDS) were administered
               Cape Town, South Africa  at 10–12 months.
               2 Department of Pathology,   Results: Of 29 infants assessed, 23 (79%) were girls. Mean birth weight was 3002 ± 501 g.
               Stellenbosch University,   Twenty-four  mothers  (83%)  received  ART  during  pregnancy.  Seven  (24%)  infants  were
               Cape Town, South Africa  diagnosed HIV+ within 48 h of birth. Median [interquartile range] viral load (VL) at
                                        diagnosis was 3904 [259–16 922] copies/mL, age starting ART was 6.0 [3–10] days and age
               3 Department of Psychiatry,
               Michigan State University,   at VL suppression was 19.1 [15–36] weeks. At the GMDS assessment, nine (31%) participants
               East Lansing, United States  had detectable VL and 26 (90%) had World Health Organization (WHO) clinical stage
                                        I disease. The GMDS was performed at a mean age of 11.5 ± 0.8 months. Mean quotients
               4 Department of Neurology   were within the average range: Global Griffiths score was 103.6 ± 10.9 and mean quotients
               and Ophthalmology,       on the subscales ranged from lowest 95.9 ± 13.4 for locomotor to highest 112.8 ± 11.3 for
               Michigan State University,
               East Lansing, United States  hearing-and-language.
                                        Conclusion: Preliminary findings in this small group suggest that early neurodevelopmental
               5 National Laboratory Services,
               Cape Town, South Africa  scores are within the normal range in infants with perinatal HIV infection who started ART at
                                        a median of 6 days.
               6 Division of Virology, Faculty
               of Medicine and Health   Keywords: HIV; infants; antiretroviral therapy; neurodevelopment; paediatrics.
               Sciences, Stellenbosch
               University, South Africa
                                       Introduction
               Corresponding author:
               Barbara Laughton,       HIV-infected (HIV+) children are at risk for neurodevelopmental delay. Neurologic insults
               [email protected]           develop after HIV enters the brain, creating an inflammatory state affecting neuronal and astrocyte
                                       growth and development ; the most severe manifestation being HIV encephalopathy (HIVE). HIV
                                                           1
               Dates:
               Received: 08 July 2019  encephalopathy rates range from 6% to 30%, with higher rates in low- and middle-income
               Accepted: 18 Aug. 2019  countries especially with delayed initiation of combination antiretroviral therapy (ART). 2,3,4,5
               Published: 30 Oct. 2019  These consequences place a great burden on the social and healthcare systems.

                                       Antiretroviral therapy has decreased the incidence of HIVE,  and when initiated between 3 and
                                                                                       6
                                       9  months of age, it improves clinical and neurodevelopmental outcomes. 7,8,9,10  Nevertheless,
                                       studies describing permanent deficits or lack of catch-up suggest that prevention is better than
                                       reversal of HIVE. 11,12,13  From 2016, the World Health Organization (WHO) introduced birth testing
                                       and recommended starting ART as soon as possible once HIV infection is confirmed.  Since the
                                                                                                           14
                                       report of temporary remission in the Mississippi baby after very early ART,  there is increasing
                                                                                                    15
                                       evidence that early ART in perinatally infected children improves infant outcomes.  Early ART
                                                                                                          16
               Read online:            can limit HIV reservoir size, and when started before 2 months of age, it is associated with fewer
               Read online:
                        Scan this QR   infected  and  transcriptionally  active  cells  and  less  infectious  virus  recovery. 17,18,19,20,21,22,23,24
                        Scan this QR
                        code with your
                        code with your
                        smart phone or
                        smart phone or
                        mobile device   How to cite this article: Laughton B, Naidoo S, Dobbels EFMT, et al. Neurodevelopment at 11 months after starting antiretroviral therapy
                        mobile device
                        to read online.
                        to read online.  within 3 weeks of life. S Afr J HIV Med. 2019;20(1), a1008. https://doi.org/10.4102/sajhivmed.v20i1.1008
                                       Copyright: © 2019. The Authors. Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License.
                                           http://www.sajhivmed.org.za 367  Open Access
   369   370   371   372   373   374   375   376   377   378   379